Order book Growth Can't Hide the Execution Crisis
Sterling and Wilson reported a 103.5% surge in profit, but the bounce came from the prior year's arbitration loss reversal—not growth. The real story: a ₹12,481 Cr order book masking stalled execution, flat costs crushing margins, and guidance cut from 10-15% to 'up to 10%.'
₹16.8 Cr
+103.5% YoY
–₹478 Cr
arbitration loss (reversal impact)
~₹70 Cr
vs. –₹439 Cr prior year; recovery-driven
Sterling and Wilson's headline profit looks explosive until you scratch the surface. The prior-year quarter posted a ₹478 Cr loss from an arbitration settlement; reversing that loss in the first half this year created a ₹70 Cr profit swing that has nothing to do with operational excellence. The company's underlying earnings remain thin—net margin is 1.1%, EBITDA margin is 3.7%, and both are flat year-over-year despite claims of operational improvement. The real profit story this quarter is not a growth story at all.
What the quarter really was
Revenue fell 12.6% year-over-year to ₹1,528 Cr in Q2. The first half delivered ₹3,118 Cr—down 11% versus the prior year. On the prior earnings call, management guided for 10–15% growth in FY27 excluding Reliance orders; on this call, that guidance was downgraded to 'up to 10%.' In the same breath, management claimed the second half would be 'heavily loaded' with execution on a ₹12,481 Cr order book. The tension here is the entire quarter: a fortress balance sheet and fortress order book, undermined by execution delays, rising costs, and margin pressure that makes the headline numbers look far stronger than the underlying business.
Gross margin improved to 9.2% from 8.9%
Q2 gross profit ₹140 Cr at 9.2% margin; supported. But EBITDA margin flat at 3.7%—overheads ₹84 Cr eating the gain.
Supported, but hollow
Q2 is a transition; Q3 & Q4 will be heavily loaded
4 Indian projects (Coal India, NTPC) + 4 international projects not yet started. No NTP dates disclosed. Egypt project (West Minya) moving, but monsoon-dependent.
Overstated
O&M grew 55% in Q2 to ₹99 Cr; portfolio now 18.9 GW
O&M ₹99 Cr confirmed; portfolio growth real. But O&M is only 6.5% of Q2 revenue; long way to go to the ₹400–450 Cr annual guidance.
Supported, but scale matters
Order book ₹12,481 Cr; 34% higher than a year ago
Order book verified; 2.5x annual revenue. 56% India, 44% international. But 40% of April 2026 base remains stalled; revenue realization delayed.
Partial (realization timeline unclear)
Maintaining 10% growth guidance for FY27
Prior guidance 10–15%; now 'up to 10%' (upper bound cut from 15% to 10%). H1 delivered –11% YoY.
Downgraded
What changed on this call
Three substantive shifts: Guidance was downgraded from 10–15% growth to 'up to 10%'—a material retreat after H1's 11% YoY miss. Execution timelines slipped visibly; projects expected to start in mid-Q2 are now revealing themselves as stalled, awaiting LOA (letter of award) or NTP (notice to proceed) from customers or financing partners, with no restart dates committed. The O&M portfolio accelerated to 18.9 GW (from 13.5 GW in March), now 50–50 own EPC versus third-party contracts, promising recurring income of ₹400+ Cr annually at 20% margins—a real positive. But domestic segment headwinds are undeniable: ALMM-II (the domestic cell mandate) is driving module costs up 15–17%, transmission constraints in Rajasthan and Gujarat are bottlenecking solar projects, and competitive intensity is compressing margins as smaller players undercut to stay alive.
₹12.5k Cr order book at 2.5x annual sales; fortress for a 3–4 year pipeline
18.9 GW O&M portfolio generating steady ₹99–100 Cr quarterly at 20%+ margins
International presence (Egypt, South Africa, Spain, Italy) provides margin arbitrage vs. domestic
Gross margin stable; company has pricing power on EPC contracts
Reported profit +103.5%, but driven by prior-year loss reversal, not core growth
Guidance downgraded from 10–15% to 'up to 10%'; credibility at C grade
40% of order base stalled; 4 Indian + 4 international projects without NTP, no timelines
Recurring overheads flat at ₹84 Cr despite 12.6% YoY revenue decline; zero operating leverage
Domestic margin pressure from ALMM, transmission constraints, competition; EPC staying at 8-10% (low end)
H2 ramp is management hope, not demonstrated capability; prior call's H2 promise missed
Risks, ranked by how much they should concern a holder
Execution delays on 40% of order book (4 Indian + 4 international projects stalled)
HIGHEach month of delay costs ~₹200 Cr annualized revenue. If projects don't start by Q3, H2 ramp will miss, dragging FY27 growth to <10% and likely triggering another guidance cut.
Domestic EPC margin compression from ALMM, transmission, competition
HIGHALMM mandate (domestic cell use) costs 15–17% more. Transmission bottlenecks force reworked PPAs. Smaller competitors underpricing. Domestic segment is ~70% of order book; margins may stay at 8% or slip further.
Overheads flat despite 12.6% revenue decline; zero operating leverage
HIGHRecurring overheads ₹84 Cr/quarter unchanged. As % of revenue, they rose from ~4.5% to 5.5%. If revenue ramp doesn't materialize, absolute cost base becomes unsustainable; EBITDA margin will compress further.
H2 ramp does not materialize; guidance missed a second time
HIGHPrior call promised H2 sharp ramp; H1 down 11% YoY. If Q3 & Q4 revenue underperforms 'heavily loaded' expectation, credibility evaporates and stock re-prices lower.
Financing delays on NTPC / Coal India projects extend into FY28
MEDIUM2 of the 4 stalled Indian projects await final NTP from utilities and financing partners. If delays extend, domestic capex will flag, cascading to fewer new awards.
ALMM cell capacity constraint extends past Dec 2027; consolidation delayed
MEDIUMManagement expects cell capacity to reach 100 GW by Dec 2027, easing prices and restoring award flow. If consolidation is delayed, margin pressure and project deferrals continue into FY28.
How the street is positioned
The market has already priced in the execution concerns. The stock fell 5.42% on day 1 of the result announcement (delivery 50.6%). Broader context: Sterling and Wilson is down 82% from its all-time high of ₹828, trading at ₹148.43, below its 20-day, 50-day, and 200-day moving averages (₹167, ₹181, ₹197 respectively). The RSI is 29.9—oversold territory, but not a buy signal without a catalyst. Foreign investors are exiting: FII ownership slipped from 6.97% in Q1 FY27 to 5.06% now (–191 bps), while domestic investors nibbled at ₹4.80% (up from 3.19%, +161 bps). The bulk deal tape is thin; April 2026 saw dealer activity in the ₹217–₹226 range, but recent activity is muted. No promoter/insider-linked selling is flagged near recent highs.
The valuation washout and FII exit signal that institutions have lost confidence in the near-term execution story. DII nibbling suggests some see value at depressed levels, but the contrarian play depends entirely on H2 delivery. If Q3 revenue is ₹1,300 Cr or below, the stock will likely gap lower; if it hits ₹2,600 Cr or above, the ramp narrative gains traction and the oversold technicals could snap back. The market is waiting for proof.
1 · Q3 project starts: Do the 4 Indian + 4 international projects actually commence?
NTP on Coal India (2), NTPC (2), Rajasthan IPP, Egypt West Minya, South Africa BESS. If 3+ projects start, revenue run-rate will accelerate. If 0–1 start, H2 ramp is off.
2 · Q3 & Q4 revenue delivery: Does management hit ₹2,600 Cr per quarter?
That's the threshold for 'heavily loaded' H2 and 10% FY27 growth. If H2 (Q3 + Q4) totals less than ₹5,000 Cr, guidance will be missed and likely cut again.
3 · Domestic EPC margin stabilization: ALMM cost pressure and competitive intensity
Watch gross margin trajectory. If it dips below 9%, absolute EBITDA margin will compress further from 3.7%. Cell capacity ramp (100 GW by Dec 2027) is the lever; if delayed, pressure persists into FY28.
Sterling and Wilson Renewable Energy is executing steadily in a tough environment, but execution is steady—not step-change. A ₹12.5k Cr order book and 18.9 GW O&M portfolio are fortress assets, but they cannot hide the credibility gap created by missed prior-call promises, flat overheads crushing margins, and visible execution delays. Management cut guidance from 10–15% to 'up to 10%,' H1 revenue is down 11% YoY, and the H2 ramp is a hope, not a demonstrated capability.
The stock is deeply discounted (down 82% from ATH) and oversold (RSI 29.9), but the technicals are not a reason to buy without a fundamental inflection. That inflection comes next quarter: if Q3 revenue exceeds ₹2,600 Cr and projects are demonstrably underway, the debate shifts. If not, the stock will likely re-price lower and guidance will be missed a second time.
The number to track from here is Q3 revenue. Everything else—the order book, the O&M portfolio, the long-term optionality—is real. But none of it matters if H2 execution doesn't deliver.
Informational and educational content only. Not investment advice.